Global Cancer Screening Market (2018-2023)

Publisher Name :
Date: 19-Sep-2018
No. of pages: 100

Global cancer screening market

The cancer screening market is witnessing a rapid upsurge due t- a rapid rise in the number of cancer cases. There lies an immediate need t- seek early diagnosis and precautionary measures. The growth of the market lies in the adoption of innovative screening technologies t- cater t- the cause. High-scale investments are being adopted by entities on diagnostic instruments along with collaboration with the government t- ensure instrument accessibility. The global cancer screening market is expected t- grow at a compound annual growth rate (CAGR) of 11% during the forecast period. The market is expected t- return a revenue of USD 152.10 Bn by 2023.

The cancer screening market is segmented based on the type of end users (hospitals, laboratory, independent physicians and clinics), screening type (laboratory, genetic, imaging, biopsy, and endoscopy) and application type (lung, breast, melanoma, kidney and colorectal). North America and Europe will be the leading regions for the market. Asia-Pacific is the fastest growing region for the cancer screening market while Latin America needs t- work on its economic scenari- t- fulfil the region's growing need for cancer diagnosis.

Key growth factors

The rise in the number of cancer cases and growing awareness among people t- seek preventive measures along with government-centered initiatives towards cancer prevention is driving the cancer screening market. Prevention calls for innovative methodologies and technologies t- be accessible for early diagnosis.

Threats and key players

There lies an underlying threat t- provide affordable and accessible treatment t- all. Along with this providing transparency and safety of medical procedures will be a key challenge for the cancer screening market.

The key players operating in this market are GE healthcare (Illinois), Siemens Healthineers (Germany), Abbott Diagnostics (U.S.), F.Hoffmann-La Roche (Switzerland), Therm- Fisher Scientific (U.S.), Hologic Inc. (U.S.), Becton Dickinson and Company (New Jersey), Qiagen (Germany), Philips (Netherlands) and Illumina (California).

What is covered in the report?

1. Overview of the cancer screening market.

2. Market drivers and challenges in the cancer screening market.

3. Market trends in the cancer screening market.

4. Historical, current and forecasted market size data for segments based on the type of end users (hospitals, laboratories ,independent physicians and clinics).

5. Historical, current and forecasted market size data for segments based on screening type (laboratory, genetic, imaging, biopsy and endoscopy).

6. Historical, current and forecasted market size data for segmentation based on application (lung, breast, melanoma, kidney, colorectal)

8. Historical, current and forecasted market size data for segments based on geography (North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa)

9. Analysis of the competitive landscape and profiles of the major companies operating in the market

Why buy?

- Understand the demand for the cancer screening market t- determine the viability of the market.

- Identify the developed and emerging markets where cancer screening market is operative.

- Identify the challenge areas and address them.

- Develop strategies based on the drivers, trends and highlights for each of the segments.

- Recognize the key competitors of this market and respond accordingly.

- Knowledge of the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth.

- Define the competitive positioning by comparing the products and services with the key players in the market.

Customizations available

With the given market data, Netscribes offers customizations according t- specific needs. Write t- us at [email protected]

Global Cancer Screening Market (2018-2023)

Table of Contents

Chapter 1: Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered in this study
1.3. Executive summary

Chapter 2: Cancer screening market - market overview
2.1. Global market overview - market trends, market attractiveness analysis, geography-wise market revenue (USD)
2.2. Global - market drivers and challenges
2.3. Value chain analysis - cancer screening market
2.4. Porter's five forces analysis
2.5. Market segmentation based on type of end users (hospitals, laboratory, independent physicians and clinics)
2.3. a. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.3. b. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.3. c. Independent physicians and clinics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. Market segmentation based on screening type (laboratory, genetic, imaging, biopsy and endoscopy)
2.4. a. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.4. b. genetic - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.4. c. Imaging - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.4. d. Biopsy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations.
2.4. e. Endoscopy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations.
2.7. Market segmentation based on application type (lung, breast, melanoma, kidney and colorectal)
2.7. a. Lung cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. b. Breast cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. c. Melanoma - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. d. Kidney - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations.
2.7. e. Colorectal - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations.

Chapter 3: Competitive landscape
3.1. GE Healthcare
3.1. a. Company snapshot
3.1. b. Product offerings
3.1. c. Strategic initiatives
3.1. d. Geographical presence
3.1. e. Key numbers
3.2. Siemens Healthineers
3.2. a. Company snapshot
3.2. b. Product offerings
3.2. c. Strategic initiatives
3.2. d. Geographical presence
3.2. e. Key numbers
3.3. Abbott Diagnostics
3.3. a. Company snapshot
3.3. b. Product offerings
3.3. c. Strategic initiatives
3.3. d. Geographical presence
3.3. e. Key numbers
3.4. F. Hoffmann-La Roche AG
3.4. a. Company snapshot
3.4. b. Product offerings
3.4. c. Strategic initiatives
3.4. d. Geographical presence
3.4. e. Key numbers
3.5. Thermo Fisher Scientific
3.5. a. Company snapshot
3.5. b. Product offerings
3.5. c. Strategies initiatives
3.5. d. Geographical presence
3.5. e. Key numbers
3.6. Hologic Inc.
3.6. a. Company snapshot
3.6. b. Product offerings
3.6. c. Strategies initiatives
3.6. e. Geographical presence
3.6. f. Key numbers
3.7. Becton, Dickinson and Company
3.7. a. Company snapshot
3.7. b. Product offerings
3.7. C. Strategic initiatives
3.7. e. Geographical presence
3.7. f. Key numbers
3.8. Qiagen
3.8. a. Company snapshot
3.8. b. Product offerings
3.8. c. Strategic initiatives
3.8. e. Geographical presence
3.8. f. Key numbers
3.9. Philips
3.9. a. Company snapshot
3.9. b. Product offerings
3.9. c. Strategic initiatives
3.9. e. Geographical presence
3.9. f. Key numbers
3.10. Illumina
3.10. a. Company snapshot
3.10. b. Product offerings
3.10. c. Strategic initiatives
3.10. e. Geographical presence
3.10. f. Key numbers

Chapter 4: Conclusion

Chapter 5: Appendix
5.1. List of tables
5.2. Assumptions
5.3. Research and methodology
5.4. About Netscribes Inc.
  • Global PSA Test Market Growth 2020-2025
    Published: 11-Feb-2020        Price: US 3660 Onwards        Pages: 161
    According to this study, over the next five years the PSA Test market will register a 10.8% CAGR in terms of revenue, the global market size will reach $ 698.1 million by 2025, from $ 463.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in PSA Test business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of PSA Test market by type, application, key manufa......
  • Succeeding in the 2020 Global Cancer Diagnostics Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 10-Feb-2020        Price: US 27500 Onwards        Pages: 1200
    LeadingMarketResearch.com's new report is a seven-country strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market......
  • Succeeding in the 2020 Europe Cancer Diagnostics Market: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 10-Feb-2020        Price: US 17500 Onwards        Pages: 820
    LeadingMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and su......
  • Succeeding in the 2020 France Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 10-Feb-2020        Price: US 4500 Onwards        Pages: 585
    LeadingMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the French cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expans......
  • Succeeding in the 2020 Germany Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 10-Feb-2020        Price: US 4500 Onwards        Pages: 585
    LeadingMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the German cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expans......
  • Succeeding in the 2020 Italy Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 10-Feb-2020        Price: US 4500 Onwards        Pages: 570
    LeadingMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Italian cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expan......
  • Succeeding in the 2020 Japan Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 10-Feb-2020        Price: US 4500 Onwards        Pages: 590
    LeadingMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Japanese cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expa......
  • Succeeding in the 2020 Spain Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 10-Feb-2020        Price: US 4500 Onwards        Pages: 565
    LeadingMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Spanish cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expan......
  • Succeeding in the 2020 UK Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 10-Feb-2020        Price: US 4500 Onwards        Pages: 565
    LeadingMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the UK cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs